CERVETTO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 8.495
Totale 8.495
Nazione #
IT - Italia 8.495
Totale 8.495
Città #
Genova 5.068
Genoa 1.411
Rapallo 1.057
Vado Ligure 936
Bordighera 23
Totale 8.495
Nome #
1,2-dihydro-2-oxo-pyridine-3-carboxamide derivative as multi-target modulator of endocannabinoid system for an innovative therapeutic approach in multiple sclerosis 267
A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes 179
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 168
A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence 163
Calcium-permeable AMPA receptors trigger vesicular glutamate release from Bergmann gliosomes 152
Inhibition of presynaptic release-facilitatory kainate autoreceptors by extracellular cyclic GMP 151
Carbenoxolone inhibits volume-regulated anion conductance in cultured rat cortical astroglia 150
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex. 146
5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices 145
Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals. 142
Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study 139
Near infrared laser photons induce glutamate release from cerebrocortical nerve terminals 137
Expression of PINK1 in the brain, eye and ear of mouse during embryonic development 136
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1 135
Perinatal hypoxia affects neuronal and glial P2X7 receptor activity in neonatal and adult rat 134
Glutamate Excitotoxicity Linked to Spermine Oxidase Overexpression 134
Astrocyte-dependent vulnerability to excitotoxicity in spermine oxidase-overexpressing mouse 129
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 129
In vitro modulation of gamma amino butyric acid (GABA) receptor expression by bone marrow stromal cells 122
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein. 119
Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: Control by presynaptic 5-HT1D receptors 119
Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X(7)-Evoked Glutamate Release 116
Identification of PINK1 in the brain, eye and ear of mouse during embryonic development. 115
Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes 115
Cochlear cells: P2X7 receptor is a candidate for glutamate release 114
Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation 114
In vitro homogeneous and heterogeneous interconnected neuronal cultures: exploring expressed dynamics and functional connectivity 112
Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals 109
GABAA and strychnine-sensitive glycine receptors modulate NMDA-evoked acetylcholine release from rat spinal motoneurons: a possible role in neuroprotection 108
Extracellular cGMP control of kainate receptor activation in rat cerebellar astrocyte processes 104
Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes. 103
Neuronal cultures coupled to Micro-Electrode Arrays as a new tool for neurotoxicological evaluation 102
Motor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism 93
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 91
P2X7 presynaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release 91
Ca2+ permeable AMPA receptors are coupled to vesicular glutamate release from Bergmann glia processes 86
Exosomes from astrocyte processes: Signaling to neurons 80
A2A-D2 receptor-receptor interaction in striatal astrocyte processes: homocysteine modulation of glutamate release 77
Presynaptic P2X7 receptor function following perinatal hypoxia 76
P2X7 receptor as a candidate for glutamate release in cochlear cells 76
Ca2+ permeable AMPA receptors evoke glutamate release from Bergmann glia processes 76
P2X7 antagonism in a mouse model of Amyotrophic Lateral Sclerosis: gender dependency 76
The C-terminal domain is required for the P2X7 receptor functioning as a route for glutamate release 76
Purified glial processes isolated from rat cerebellum are endowed with Ca2+ permeable AMPA receptors 75
In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOd1/G93A(+) mouse model of amyotrophioc lateral sclerosis. 75
Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes 74
NO-cGMP pathway controls network activity in dissociated cortical neurons coupled to Micro-Electrode Arrays 74
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 72
Extracellular cGMP modulates presynaptic kainate receptors 70
Calmidazolium a selective inhibitor of exocytotic glutamate release evoked by P2X7 receptor activation 67
Biochemical and biophysical evidence for the A2A-D2 heteroreceptors in striatal astrocytes 67
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 66
IL-1 alpha and modulation of spinal glutamate release: protection against oxaliplatin-induced neuropathic pain 65
A2A-D2 heterodimers control glutamate release from striatal astrocytes 65
Role of spermine oxidase in modulation of glutamate receptors and transporters during excitotoxic stress 63
Release regulating mGlu2-preferring and mGlu3 preferring autoreceptors in CNS 62
Gamma amino butyric acid (GABA) receptors in induced neuron-like Bone Marrow Stromal Cells 61
NO-cGMP pathway controls network activity in dissociated cortical neurons coupled to Micro-Electrode Arrays 61
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2-preferring and mGlu3-preferring autoreceptors and their role in demyelinating disease. 61
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2/3 autoreceptors in the spinal cord. 61
Modulation of kainate receptors by extracellular cGMP 60
Astrocyte-dependent susceptibility to excitotoxicity in spermine oxidase overexpressing mouse 60
Increased vulnerability to excitotoxicity in spermine oxidase overexpressing mouse: astrocyte-dependency 60
Striatal astrocytic processes and glutamate release: effects of homocysteine and A2A-D2 receptor-receptor interaction 59
Vulnerability to seizures and astrocytes: a model mouse of deregulated polyamine metabolism 59
A2A-D2 heterodimers on striatal astrocytes: effects of homocysteine 59
A2A-D2 heterodimers on striatal astrocytes: biochemical and biophysical evidences 59
Bergmann glial processes: Ca2+ permeable AMPA receptors are coupled to vesicular glutamate release 57
Susceptibility to excitotoxicity and epileptic seizures in spermine oxidase overexpressing mouse: astrocyte dependency 57
Chemotherapy-induced neuropathic pain: P2X7 receptor and recruitment of pannexin1 56
Striatal glutamatergic transmission: astrocytic A2A-D2 receptor-receptor interaction and homocysteine 56
In vitro neurotoxicity testing: Functional neuron-specific endpoints 56
Ca2+ permeable AMPA receptors are present on purified glial processes isolated from rat cerebellum 54
A2A-D2 heteromerization on striatal astrocytes: evidence and modulation of glutamate release 54
Heterodimer of A2A and Oxytocin Receptors Regulating Glutamate Release in Adult Striatal Astrocytes 54
Gender-dependent effect of P2X7 antagonism in a mouse model of ALS 51
A2A-D2 heterodimers on striatal astrocytes 51
Native A2A-D2 receptor-receptor interaction in striatal astrocyte processes: modulation of glutamate release 50
Bioeconomia e Ricerca Farmacologica 50
Reactive astrocytosis in a mouse model of chronic polyamine catabolism activation 49
Native A2A-D2 heterodimers: modulation of glutamate release from striatal astrocyte processes 48
A2A-D2 heterodimers on striatal astrocytes: effects of homocysteine 48
IL-1a evokes protective signals against oxaliplatin neurotoxicity by a spinal modulation of glutamate release 47
Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate release in mouse cortex and spinal cord 46
Transgenic Mouse Overexpressing Spermine Oxidase in Cerebrocortical Neurons: Astrocyte Dysfunction and Susceptibility to Epileptic Seizures 46
Seizure vulnerability linked to astrocytes: a model mouse of deregulated polyamine metabolism 45
Oxaliplatin neuropathic pain: involvement of the P2X7 receptor and recruitment of pannexin1 45
Reti neuronali su MultiElectrode Arrays (MEAs): metodo alternativo per la valutazione di neurotossicità 45
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 41
Native A2A-D2 heterodimers modulate glutamate release from striatal astrocyte processes 40
Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing 39
Striatal astrocytes and glutamate release: A2A-D2 receptor-receptor interaction 38
Striatal astrocytes: functional evidence of A2A-D2 heterodimerization and modulation of glutamate release 38
Vesicular glutamate release from feeder-free hiPSC-derived neurons 37
Astrocyte signalling to neurons through exosomes 37
null 35
Striatal astrocytes: biochemical and biophysical evidence of A2A-D2 heterodimerization 35
Signals from astrocytes to neurons: exosomes released from astrocytic processes 33
A2A and Oxytocin receptor heteromers: exploring their role as modulators of glutamate release in adult striatal astrocytes 32
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 31
Totale 8.262
Categoria #
all - tutte 30.199
article - articoli 17.874
book - libri 0
conference - conferenze 12.325
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.326 0 0 0 0 0 176 265 97 115 384 244 45
2020/2021578 42 35 49 22 42 44 32 56 65 111 43 37
2021/20221.199 32 89 75 102 68 79 48 281 72 124 59 170
2022/20231.318 141 92 43 101 204 178 10 90 213 37 181 28
2023/20241.119 36 118 24 139 79 197 98 57 50 70 103 148
2024/20251.047 118 179 60 127 297 266 0 0 0 0 0 0
Totale 8.752